Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Bronchogenic 1

Interventions

Carboplatin 12 Pemetrexed 8 pembrolizumab 4 Paclitaxel 4 Cisplatin 4 durvalumab 3 Radiosurgery 3 Gemcitabine 3 selpercatinib 2 pralsetinib 2 osimertinib 2 camrelizumab 2 atezolizumab 2 Docetaxel 2 taletrectinib 1 repotrectinib 1 motexafin gadolinium 1 exemestane 1 entinostat 1 ceralasertib 1 cemiplimab 1 belinostat 1 belagenpumatucel L 1 alectinib 1 Vinorelbine 1 Tyrosine Kinase Inhibitors 1 TNFSF10 protein, human 1 Radiotherapy 1 Platinum Compounds 1 Patient Reported Outcome Measures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Bronchogenic × Mediastinoscopy × Clear all

NCT00652769 2017-11-01

BOOST

University College London Hospitals

Phase 3 Completed

Carcinoma, Bronchogenic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡